| . | β Coefficient ± SEa . | P-value . |
|---|---|---|
| Resting haemodynamics | ||
| Arterial O2 saturation, % | −1.9 ± 0.8 | 0.02 |
| SVC, mmHg | 1.7 ± 0.5 | 0.003 |
| PA, mmHg | 1.6 ± 0.6 | 0.005 |
| PAWP, mmHg | 1.5 ± 0.6 | 0.01 |
| Qp, L/min | 0.4 ± 0.2 | 0.05 |
| Qs, L/min | 0.9 ± 0.3 | 0.01 |
| Cardiac index, L/min/m2 | 0.2 ± 0.1 | 0.13 |
| Stroke volume, mL | 15.3 ± 4.8 | 0.002 |
| SVR, dynes/s/cm−5 | −203 ± 83 | 0.02 |
| SVRi, dynes/s/cm−5/m2 | −141 ± 52 | 0.01 |
| VO2, mL/min/kg | −0.2 ± 0.1 | 0.01 |
| VO2, mL/min | 27.8 ± 6.8 | <0.001 |
| Exercise haemodynamics | ||
| Arterial O2 saturation, % | −2.7 ± 1.2 | 0.03 |
| SVC, mmHg | 4.0 ± 1.0 | <0.001 |
| PA, mmHg | 3.0 ± 1.0 | 0.004 |
| PAWP, mmHg | 3.1 ± 1.1 | 0.006 |
| Qs, L/min | 0.5 ± 0.4 | 0.24 |
| Stroke volume, mL | 15.9 ± 4.2 | <0.001 |
| SVR, dynes/s/cm−5 | −94 ± 47 | 0.05 |
| SVRi, dynes/s/cm−5/m2 | −60 ± 32 | 0.07 |
| VO2, mL/min/kg | −1.9 ± 0.5 | <0.001 |
| Angiography | ||
| Odds ratio (95% CI)a | P-value | |
| Veno-venous collateral | 6.5 (1.4; 30.1) | 0.02 |
| . | β Coefficient ± SEa . | P-value . |
|---|---|---|
| Resting haemodynamics | ||
| Arterial O2 saturation, % | −1.9 ± 0.8 | 0.02 |
| SVC, mmHg | 1.7 ± 0.5 | 0.003 |
| PA, mmHg | 1.6 ± 0.6 | 0.005 |
| PAWP, mmHg | 1.5 ± 0.6 | 0.01 |
| Qp, L/min | 0.4 ± 0.2 | 0.05 |
| Qs, L/min | 0.9 ± 0.3 | 0.01 |
| Cardiac index, L/min/m2 | 0.2 ± 0.1 | 0.13 |
| Stroke volume, mL | 15.3 ± 4.8 | 0.002 |
| SVR, dynes/s/cm−5 | −203 ± 83 | 0.02 |
| SVRi, dynes/s/cm−5/m2 | −141 ± 52 | 0.01 |
| VO2, mL/min/kg | −0.2 ± 0.1 | 0.01 |
| VO2, mL/min | 27.8 ± 6.8 | <0.001 |
| Exercise haemodynamics | ||
| Arterial O2 saturation, % | −2.7 ± 1.2 | 0.03 |
| SVC, mmHg | 4.0 ± 1.0 | <0.001 |
| PA, mmHg | 3.0 ± 1.0 | 0.004 |
| PAWP, mmHg | 3.1 ± 1.1 | 0.006 |
| Qs, L/min | 0.5 ± 0.4 | 0.24 |
| Stroke volume, mL | 15.9 ± 4.2 | <0.001 |
| SVR, dynes/s/cm−5 | −94 ± 47 | 0.05 |
| SVRi, dynes/s/cm−5/m2 | −60 ± 32 | 0.07 |
| VO2, mL/min/kg | −1.9 ± 0.5 | <0.001 |
| Angiography | ||
| Odds ratio (95% CI)a | P-value | |
| Veno-venous collateral | 6.5 (1.4; 30.1) | 0.02 |
CI, confidence interval; PA, pulmonary artery; PAWP, pulmonary artery wedge pressure; Qp, pulmonary flow; Qs, systemic flow; SVC, superior vena cava; SE, standard error; SVR, systemic vascular resistance; SVRi, systemic vascular resistance index; VO2, oxygen consumption.
Values in bold indicate statistical significance (defined as P-value <0.05).
aβ Coefficient and odds ratio represent the association between obesity (vs. non-obesity) as the predictor variable and individual haemodynamic measurements on the outcome variable, while adjusting for age, pacemaker, ventricular ejection, ventricular morphology, and atrioventricular valve regurgitation.
| . | β Coefficient ± SEa . | P-value . |
|---|---|---|
| Resting haemodynamics | ||
| Arterial O2 saturation, % | −1.9 ± 0.8 | 0.02 |
| SVC, mmHg | 1.7 ± 0.5 | 0.003 |
| PA, mmHg | 1.6 ± 0.6 | 0.005 |
| PAWP, mmHg | 1.5 ± 0.6 | 0.01 |
| Qp, L/min | 0.4 ± 0.2 | 0.05 |
| Qs, L/min | 0.9 ± 0.3 | 0.01 |
| Cardiac index, L/min/m2 | 0.2 ± 0.1 | 0.13 |
| Stroke volume, mL | 15.3 ± 4.8 | 0.002 |
| SVR, dynes/s/cm−5 | −203 ± 83 | 0.02 |
| SVRi, dynes/s/cm−5/m2 | −141 ± 52 | 0.01 |
| VO2, mL/min/kg | −0.2 ± 0.1 | 0.01 |
| VO2, mL/min | 27.8 ± 6.8 | <0.001 |
| Exercise haemodynamics | ||
| Arterial O2 saturation, % | −2.7 ± 1.2 | 0.03 |
| SVC, mmHg | 4.0 ± 1.0 | <0.001 |
| PA, mmHg | 3.0 ± 1.0 | 0.004 |
| PAWP, mmHg | 3.1 ± 1.1 | 0.006 |
| Qs, L/min | 0.5 ± 0.4 | 0.24 |
| Stroke volume, mL | 15.9 ± 4.2 | <0.001 |
| SVR, dynes/s/cm−5 | −94 ± 47 | 0.05 |
| SVRi, dynes/s/cm−5/m2 | −60 ± 32 | 0.07 |
| VO2, mL/min/kg | −1.9 ± 0.5 | <0.001 |
| Angiography | ||
| Odds ratio (95% CI)a | P-value | |
| Veno-venous collateral | 6.5 (1.4; 30.1) | 0.02 |
| . | β Coefficient ± SEa . | P-value . |
|---|---|---|
| Resting haemodynamics | ||
| Arterial O2 saturation, % | −1.9 ± 0.8 | 0.02 |
| SVC, mmHg | 1.7 ± 0.5 | 0.003 |
| PA, mmHg | 1.6 ± 0.6 | 0.005 |
| PAWP, mmHg | 1.5 ± 0.6 | 0.01 |
| Qp, L/min | 0.4 ± 0.2 | 0.05 |
| Qs, L/min | 0.9 ± 0.3 | 0.01 |
| Cardiac index, L/min/m2 | 0.2 ± 0.1 | 0.13 |
| Stroke volume, mL | 15.3 ± 4.8 | 0.002 |
| SVR, dynes/s/cm−5 | −203 ± 83 | 0.02 |
| SVRi, dynes/s/cm−5/m2 | −141 ± 52 | 0.01 |
| VO2, mL/min/kg | −0.2 ± 0.1 | 0.01 |
| VO2, mL/min | 27.8 ± 6.8 | <0.001 |
| Exercise haemodynamics | ||
| Arterial O2 saturation, % | −2.7 ± 1.2 | 0.03 |
| SVC, mmHg | 4.0 ± 1.0 | <0.001 |
| PA, mmHg | 3.0 ± 1.0 | 0.004 |
| PAWP, mmHg | 3.1 ± 1.1 | 0.006 |
| Qs, L/min | 0.5 ± 0.4 | 0.24 |
| Stroke volume, mL | 15.9 ± 4.2 | <0.001 |
| SVR, dynes/s/cm−5 | −94 ± 47 | 0.05 |
| SVRi, dynes/s/cm−5/m2 | −60 ± 32 | 0.07 |
| VO2, mL/min/kg | −1.9 ± 0.5 | <0.001 |
| Angiography | ||
| Odds ratio (95% CI)a | P-value | |
| Veno-venous collateral | 6.5 (1.4; 30.1) | 0.02 |
CI, confidence interval; PA, pulmonary artery; PAWP, pulmonary artery wedge pressure; Qp, pulmonary flow; Qs, systemic flow; SVC, superior vena cava; SE, standard error; SVR, systemic vascular resistance; SVRi, systemic vascular resistance index; VO2, oxygen consumption.
Values in bold indicate statistical significance (defined as P-value <0.05).
aβ Coefficient and odds ratio represent the association between obesity (vs. non-obesity) as the predictor variable and individual haemodynamic measurements on the outcome variable, while adjusting for age, pacemaker, ventricular ejection, ventricular morphology, and atrioventricular valve regurgitation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
